We could not confirm the prognostic impact of s‐p53‐Abs in ESCC previously reported by Suzuki et al.10The difference can be partly explained by different cut‐off values and/or different assay systems. This evidence concerns the gene TP53 and esophageal squamous cell carcinoma.